SuperworthAgios Pharmaceuticals shares outstanding AGIO
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 59.5M
- On a year earlier
- +2.7%
- more shares
Agios Pharmaceuticals had 59.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 58.3M | +2% |
| FY2024 | 57.1M | +2% |
| FY2023 | 55.9M | +2% |
| FY2022 | 55M | +1% |
| FY2021 | 54.3M | −22% |
| FY2020 | 69.3M | +8% |
| FY2019 | 63.9M | +10% |
| FY2018 | 58.2M | +19% |
| FY2017 | 48.8M | +16% |
| FY2016 | 42.1M | +12% |
| FY2015 | 37.7M | +7% |
| FY2014 | 35.1M | +13% |
| FY2013 | 31.2M | +775% |
| FY2012 | 3.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 59.5M | +3% | |
| Q1 FY26 | 58.8M | +2% | |
| Q4 FY25 | 58.3M | +2% | |
| Q3 FY25 | 58.1M | −1% | |
| Q2 FY25 | 57.9M | +2% | |
| Q1 FY25 | 57.5M | +2% | |
| Q4 FY24 | 57.1M | +2% | |
| Q3 FY24 | 58.4M | +5% | |
| Q2 FY24 | 56.8M | +2% | |
| Q1 FY24 | 56.4M | +2% | |
| Q4 FY23 | 55.9M | +2% | |
| Q3 FY23 | 55.8M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Agios Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.